NCT06689644

Brief Summary

Nootropics are a group of medicinal substances purported to improve important cognitive functions such as learning, focus and memory. Many of these substances have demonstrated beneficial effects on cognitive performance and overall health. However, a thorough understanding of how these substances and their synergistic effects in the form of a supplement may benefit fundamental brain processes is currently lacking. In the current study, we will investigate the effects of a plant-based, nootropic supplement (https://uk.mindlabpro.com/) on perceptual decision-making (i.e. the ability to make rapid decisions based on sensory stimuli) in healthy adult participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 23, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 6, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 13, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 14, 2024

Completed
Last Updated

November 14, 2024

Status Verified

November 1, 2024

Enrollment Period

5 months

First QC Date

November 13, 2024

Last Update Submit

November 13, 2024

Conditions

Keywords

Perceptual decision-makingCognitive enhancementNootropicsEEGBrain health

Outcome Measures

Primary Outcomes (1)

  • Perceptual decision-making performance

    Choice accuracy and reaction times

    Pre- and post- 60 days of supplementation

Secondary Outcomes (1)

  • Brain network interdependencies

    Pre- and post- 60 days of supplementation

Study Arms (2)

Experimental group

EXPERIMENTAL

This group will receive the nootropic supplement for 60 days.

Dietary Supplement: Nootropics (ginkgo biloba, nicergoline, piracetam, or others)Behavioral: Perceptual decision-making performanceDevice: Electroencephalography

Control group

PLACEBO COMPARATOR

This group will receive a placebo supplement for 60 days

Dietary Supplement: PlaceboBehavioral: Perceptual decision-making performanceDevice: Electroencephalography

Interventions

Commercially available product: Mind lab pro

Experimental group
PlaceboDIETARY_SUPPLEMENT

A cellulose commonly used as a bulking agent in supplement products

Control group

A computerised cognitive task involving rapid visual categorisation of images

Control groupExperimental group

Brain signals are recorded from a 64 channel EEG system during the cognitive task

Control groupExperimental group

Eligibility Criteria

Age20 Years - 59 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Biological sciences

Leeds, United Kingdom

Location

Related Publications (1)

  • O'Reilly D, Bolam J, Delis I, Utley A. Effect of a Plant-Based Nootropic Supplement on Perceptual Decision-Making and Brain Network Interdependencies: A Randomised, Double-Blinded, and Placebo-Controlled Study. Brain Sci. 2025 Feb 21;15(3):226. doi: 10.3390/brainsci15030226.

Related Links

MeSH Terms

Interventions

Nootropic AgentsGinkgo ExtractNicergolinePiracetamElectroencephalography

Intervention Hierarchy (Ancestors)

Central Nervous System AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and UsesPlant ExtractsPlant PreparationsBiological ProductsComplex MixturesErgolinesErgot AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingAcetamidesAmidesOrganic ChemicalsAcetatesAcids, AcyclicCarboxylic AcidsPyrrolidinonesPyrrolidinesHeterocyclic Compounds, 1-RingDiagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosis

Study Officials

  • Ioannis Delis

    University of Leeds

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 13, 2024

First Posted

November 14, 2024

Study Start

October 23, 2023

Primary Completion

March 6, 2024

Study Completion

June 1, 2024

Last Updated

November 14, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

No further investigations will take place using this data with anyone outside of the current research group

Locations